Alector, Inc. - Common Stock (ALEC)

Alector Inc is a biotechnology company focused on developing innovative therapies for neurodegenerative diseases by harnessing the immune system

The company aims to discover and bring to market treatments that address the underlying mechanisms of conditions such as Alzheimer's disease. Through advanced research and a proprietary platform, Alector is dedicated to unlocking new pathways in neuroscience and providing hope for patients dealing with these challenging diseases. Their strategic approach combines drug development with a strong emphasis on understanding the interactions between the immune system and the nervous system.